Forecast for Vaccine Stocks After Coronavirus Pandemic Passes
Stephen Gardner, director at ETF Managers Group, explains why investors shouldn't be rushing to sell vaccine stocks like Moderna or BioNTech even as the spread of COVID-19 slows down.
More Videos
Inside Wealthfront’s Big IPO Moment and the Future of Robo Banks
Wealthfront’s CFO Alan Iberman talks the $2.05B IPO and the major moment for robo banking as the company bets on AI, automation, and “self-driving money."
Go Fund Yourself: Two Brands Redefining the Future of Sustainable
Power of 3re redefines renewable energy through recycling innovation. THC Grow pioneers sustainable cultivation with tech-driven transparency.
Disney's Former Head of Innovation and Creativity on How to Be Inspired at Work
Duncan Wardle, former Head of Innovation and Creativity at Disney, explains how to execute new, imaginative ideas within massive corporate enterprises
NASA Roboticist on the Emotional Connection Between Humans and Machines
Ayanna Howard, NASA roboticist and Dean of Engineering at OSU, explains integrating human emotion with AI at World Business Forum
Inside the Fed’s Decision to Cut Rates
The Fed cut rates, sparking market swings. Bill Mann unpacks the decision, the economy’s direction, policy risks, and what investors should know.
America’s Chipmaking Comeback: Why the U.S. Is Racing to Reshore Semiconductors
The Verge’s Senior Science Reporter, Justine Calma, explains how the Chips Act and federal funding are reshaping America’s chipmaking future.
